Steve Lemieux joined me to discuss ARDS. We highlight the recently published 2023 ESICM guidelines and discuss the role of phenotypes. Then we dive into the severe ARDS pharmacotherapy highlighting corticosteroids, neuromuscular blockers, and pulmonary vasodilators.
Steve Lemieux joined me to discuss ARDS. We highlight the recently published 2023 ESICM guidelines and discuss the role of phenotypes. Then we dive into the severe ARDS pharmacotherapy highlighting corticosteroids, neuromuscular blockers, and pulmonary vasodilators.
Pharmacy to Dose: The Critical Care Podcast 
Leave a comment